Compass Therapeutics, Inc. (CMPX): A Bull Case Theory
We came across a bullish thesis on Compass Therapeutics, Inc. on r/stocks by Cute_Confidence6033. In this article, we will summarize the bulls’ thesis on CMPX.
Compass Therapeutics Inc. (CMPX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 16,790,809 | $90,166,644 | -1% | 4.45% |
| 2. | OrbiMed Advisors Samuel Isaly | 15,219,994 | $81,731,368 | 1.67% | |
| 3. | Suvretta Capital Management Aaron Cowen | 14,182,379 | $76,159,375 | +1% | 1.56% |
| 4. | Vivo Capital Albert Cha And Frank Kung | 9,545,466 | $51,259,152 | 3.31% | |
| 5. | Enavate Sciences James Boylan | 7,788,150 | $41,822,366 | 8.25% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.11 | 10,000 | $21,100.00 | 6,480,825 | 2025-05-27 | Filing | |
| $1.54 | 20,000 | $30,800.00 | 21,000 | 2025-04-07 | Filing | |
| $1.42 | 20,000 | $28,400.00 | 320,000 | 2025-04-07 | Filing | |
| $3.37 | 10,000 | $33,700.00 | 6,021,873 | 2023-03-10 | Filing | |
| $3.98 | 20,000 | $79,600.00 | 6,011,873 | 2023-02-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.59 | 3,571,428 | $5,678,570.52 | 0 | 2025-04-09 | Filing | |
| $1.59 | 3,571,428 | $5,678,570.52 | 0 | 2025-04-09 | Filing | |
| $4.36 | 2 | $8.72 | 1,060,414 | 2022-11-25 | Filing | |
| $4.30 | 9,569 | $41,146.70 | 1,060,416 | 2022-11-23 | Filing | |
| $4.19 | 14,929 | $62,552.51 | 1,069,985 | 2022-11-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,388,624 | $50,416,912 | 0% | |
| 2. | 8,048,374 | $43,219,768 | 0% | |
| 3. | 6,126,182 | $32,897,597 | 0.13% | |
| 4. | 4,890,525 | $26,262,119 | 0% | |
| 5. | 3,502,526 | $18,813,341 | 0% |
News See All
Compass Therapeutics' (CMPX) Tovecimig Drives Strong Analyst Sentiment
On December 3, 2025, Compass Therapeutics, Inc. (NASDAQ:CMPX) saw Canaccord analyst John Newman initiate coverage of the stock with a “Buy” rating and a $10 price target.
12 Best Multibagger Stocks to Buy Heading into 2026
As we head into 2026, the biggest question market participants are asking is whether the strong momentum this year can carry over into next year.
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement
On November 10, 2025, H.C. Wainwright’s Joseph Pantginis reiterated a “Buy” rating on Compass Therapeutics, Inc. (NASDAQ:CMPX) with a $24 price target.
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
Compass Therapeutics Inc. (CMPX) is A Buy on Wall Street on Robust Pipeline Development
Compass Therapeutics Inc. (NASDAQ:CMPX) is a must-buy penny stock to buy now. On November 10, Pipe Sandler analyst Biren Amin reiterated that Compass Therapeutics Inc.
11 Must-Buy Penny Stocks to Buy Now
Markets have continued to rally, with the S&P 500 already up by about 15% for the year.
Piper Sandler Remains Bullish on Compass Therapeutics (CMPX)
Compass Therapeutics Inc. (NASDAQ:CMPX) is one of the best stocks under $5 with highest upside potential. Compass Therapeutics Inc.
14 Stocks Under $5 with Highest Upside Potential
On October 28, Paul Tudor Jones, Tudor Investment Corporation founder and CIO and Robin Hood Foundation founder and board member, appeared on CNBC’s 'Squawk Box' to talk about the latest trends in the...
Guggenheim Sees Compass (CMPX) Potential Driven by Biliary Tract Cancer Pipeline
Compass Therapeutics Inc. (NASDAQ:CMPX) is one of the best multibagger stocks to invest in right now.
Hedge Fund Resource Center Billionaire Hedge Funds
